Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common stock, par value $0.001 per share (the "Common Stock")
-
Shares outstanding
-
138,764,349
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
55,874,420
-
Shares change
-
+4,225,083
-
Total reported value, excl. options
-
$1,071,112,217
-
Value change
-
+$87,737,206
-
Put/Call ratio
-
58%
-
Number of buys
-
81
-
Number of sells
-
45
-
Price
-
$19.17
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) as of Q3 2018
As of 30 Sep 2018 ARROWHEAD PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (the "Common Stock") (ARWR) had 170 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 55,874,420 shares of stock of the company.
Largest 10 holders included OppenheimerFunds, Inc., RTW INVESTMENTS, LP, BlackRock Inc., FIRST MANHATTAN CO, STATE STREET CORP, Vanguard Group Inc, Vivo Capital, LLC, FMR LLC, Invesco Ltd., and NORTHERN TRUST CORP.
This table shows 170 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.